Published in Proc Natl Acad Sci U S A on July 01, 1988
Neurocircuitry of addiction. Neuropsychopharmacology (2010) 14.22
A translational profiling approach for the molecular characterization of CNS cell types. Cell (2008) 8.69
Cannabinoid receptor localization in brain. Proc Natl Acad Sci U S A (1990) 5.48
Evidence for sugar addiction: behavioral and neurochemical effects of intermittent, excessive sugar intake. Neurosci Biobehav Rev (2007) 5.22
Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications. Nat Rev Neurosci (2011) 4.88
Chronic stress, drug use, and vulnerability to addiction. Ann N Y Acad Sci (2008) 4.60
A multistep general theory of transition to addiction. Psychopharmacology (Berl) (2013) 4.01
Drug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodeling. Neuron (2011) 3.93
Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress. Proc Natl Acad Sci U S A (2005) 3.83
Imaging dopamine's role in drug abuse and addiction. Neuropharmacology (2008) 3.28
Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accumbens. J Neurosci (2001) 3.09
Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc Natl Acad Sci U S A (1992) 3.02
A unified framework for addiction: vulnerabilities in the decision process. Behav Brain Sci (2008) 2.83
Biological substrates of reward and aversion: a nucleus accumbens activity hypothesis. Neuropharmacology (2008) 2.80
Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens. Proc Natl Acad Sci U S A (1995) 2.66
Neuropharmacology of alcohol addiction. Br J Pharmacol (2008) 2.65
Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory. Proc Natl Acad Sci U S A (2007) 2.62
Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence. Neuropsychopharmacology (2007) 2.61
A neurobiological basis for substance abuse comorbidity in schizophrenia. Biol Psychiatry (2001) 2.58
Cigarette smoking saturates brain alpha 4 beta 2 nicotinic acetylcholine receptors. Arch Gen Psychiatry (2006) 2.53
Addiction circuitry in the human brain. Annu Rev Pharmacol Toxicol (2011) 2.51
Dynorphin and the pathophysiology of drug addiction. Pharmacol Ther (2007) 2.51
How addictive drugs disrupt presynaptic dopamine neurotransmission. Neuron (2011) 2.50
Reward processing by the opioid system in the brain. Physiol Rev (2009) 2.46
Abolished cocaine reward in mice with a cocaine-insensitive dopamine transporter. Proc Natl Acad Sci U S A (2006) 2.46
Effects of kappa-opioid receptor ligands on intracranial self-stimulation in rats. Psychopharmacology (Berl) (2004) 2.35
Metabotropic glutamate receptors: from the workbench to the bedside. Neuropharmacology (2010) 2.31
Hypothalamic-pituitary-adrenal axis and sympatho-adreno-medullary responses during stress-induced and drug cue-induced cocaine craving states. Psychopharmacology (Berl) (2003) 2.27
Hyperpolarization-activated cation current (Ih) is an ethanol target in midbrain dopamine neurons of mice. J Neurophysiol (2005) 2.26
Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice. Proc Natl Acad Sci U S A (1998) 2.22
Intense sweetness surpasses cocaine reward. PLoS One (2007) 2.22
Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice. Proc Natl Acad Sci U S A (2003) 2.21
Inhibitory control and emotional stress regulation: neuroimaging evidence for frontal-limbic dysfunction in psycho-stimulant addiction. Neurosci Biobehav Rev (2007) 2.20
Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference. Proc Natl Acad Sci U S A (2001) 2.19
Synaptic overflow of dopamine in the nucleus accumbens arises from neuronal activity in the ventral tegmental area. J Neurosci (2009) 2.16
The neurocircuitry of addiction: an overview. Br J Pharmacol (2008) 2.11
Opiate versus psychostimulant addiction: the differences do matter. Nat Rev Neurosci (2011) 2.05
Cocaine induces striatal c-fos-immunoreactive proteins via dopaminergic D1 receptors. Proc Natl Acad Sci U S A (1991) 2.04
Role of brain dopamine in food reward and reinforcement. Philos Trans R Soc Lond B Biol Sci (2006) 2.03
A genetic determinant of the striatal dopamine response to alcohol in men. Mol Psychiatry (2010) 2.02
Gene variants of brain dopamine pathways and smoking-induced dopamine release in the ventral caudate/nucleus accumbens. Arch Gen Psychiatry (2006) 2.00
Abnormal structure of frontostriatal brain systems is associated with aspects of impulsivity and compulsivity in cocaine dependence. Brain (2011) 2.00
The D2 dopamine receptor gene as a determinant of reward deficiency syndrome. J R Soc Med (1996) 1.98
Addiction: decreased reward sensitivity and increased expectation sensitivity conspire to overwhelm the brain's control circuit. Bioessays (2010) 1.97
The behavioral, anatomical and pharmacological parallels between social attachment, love and addiction. Psychopharmacology (Berl) (2012) 1.96
Social stress, therapeutics and drug abuse: preclinical models of escalated and depressed intake. Pharmacol Ther (2008) 1.94
Acute withdrawal, protracted abstinence and negative affect in alcoholism: are they linked? Addict Biol (2010) 1.93
Association between two mu-opioid receptor gene (OPRM1) haplotype blocks and drug or alcohol dependence. Hum Mol Genet (2006) 1.93
Basal Ganglia disorders associated with imbalances in the striatal striosome and matrix compartments. Front Neuroanat (2011) 1.85
Inhibition of ERK pathway or protein synthesis during reexposure to drugs of abuse erases previously learned place preference. Proc Natl Acad Sci U S A (2006) 1.84
Chronic cocaine but not chronic amphetamine use is associated with perseverative responding in humans. Psychopharmacology (Berl) (2008) 1.79
Brain monoamine oxidase A inhibition in cigarette smokers. Proc Natl Acad Sci U S A (1996) 1.78
The beta2 but not alpha7 subunit of the nicotinic acetylcholine receptor is required for nicotine-conditioned place preference in mice. Psychopharmacology (Berl) (2006) 1.76
The development and maintenance of drug addiction. Neuropsychopharmacology (2013) 1.76
Pharmacogenetic approaches to the treatment of alcohol addiction. Nat Rev Neurosci (2011) 1.74
Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings. J Neurodev Disord (2012) 1.73
Forebrain substrates of reward and motivation. J Comp Neurol (2005) 1.72
The effects of acute and repeated nicotine treatment on nucleus accumbens dopamine and locomotor activity. Br J Pharmacol (1992) 1.69
Presynaptic nicotinic receptors: a dynamic and diverse cholinergic filter of striatal dopamine neurotransmission. Br J Pharmacol (2007) 1.69
Stress-induced reinstatement of cocaine seeking is mediated by the kappa opioid system. Psychopharmacology (Berl) (2008) 1.68
Cannabinoids: reward, dependence, and underlying neurochemical mechanisms--a review of recent preclinical data. Psychopharmacology (Berl) (2003) 1.66
Development of κ opioid receptor antagonists. J Med Chem (2013) 1.61
Response-reinforcement learning is dependent on N-methyl-D-aspartate receptor activation in the nucleus accumbens core. Proc Natl Acad Sci U S A (1997) 1.61
Functional selectivity at the μ-opioid receptor: implications for understanding opioid analgesia and tolerance. Pharmacol Rev (2011) 1.61
Effect of sustained-release (SR) bupropion on craving and withdrawal in smokers deprived of cigarettes for 72 h. Psychopharmacology (Berl) (2005) 1.61
Pharmacologic mechanisms of crystal meth. CMAJ (2008) 1.60
Brain reward circuitry beyond the mesolimbic dopamine system: a neurobiological theory. Neurosci Biobehav Rev (2010) 1.57
Neuronal adaptation to amphetamine and dopamine: molecular mechanisms of prodynorphin gene regulation in rat striatum. Neuron (1995) 1.56
OPRM1 SNP (A118G): involvement in disease development, treatment response, and animal models. Drug Alcohol Depend (2010) 1.55
Behavioural and biochemical evidence for interactions between Delta 9-tetrahydrocannabinol and nicotine. Br J Pharmacol (2002) 1.53
Nicotine enhances responding with conditioned reinforcement. Psychopharmacology (Berl) (2003) 1.52
Functional brain imaging of tobacco use and dependence. J Psychiatr Res (2005) 1.52
Rapid dopamine transmission within the nucleus accumbens: dramatic difference between morphine and oxycodone delivery. Eur J Neurosci (2014) 1.51
Hierarchical recruitment of phasic dopamine signaling in the striatum during the progression of cocaine use. Proc Natl Acad Sci U S A (2012) 1.50
30 years of dynorphins--new insights on their functions in neuropsychiatric diseases. Pharmacol Ther (2009) 1.50
Behavioral functions of the mesolimbic dopaminergic system: an affective neuroethological perspective. Brain Res Rev (2007) 1.50
Addiction science: Uncovering neurobiological complexity. Neuropharmacology (2013) 1.50
Accumbens neurochemical adaptations produced by binge-like alcohol consumption. Psychopharmacology (Berl) (2007) 1.50
Ventral striatal dopamine release in response to smoking a regular vs a denicotinized cigarette. Neuropsychopharmacology (2008) 1.49
Lobelane inhibits methamphetamine-evoked dopamine release via inhibition of the vesicular monoamine transporter-2. J Pharmacol Exp Ther (2009) 1.49
Opioidergic and dopaminergic modulation of respiration. Respir Physiol Neurobiol (2008) 1.48
Dopamine signaling in the nucleus accumbens of animals self-administering drugs of abuse. Curr Top Behav Neurosci (2010) 1.46
Shared brain vulnerabilities open the way for nonsubstance addictions: carving addiction at a new joint? Ann N Y Acad Sci (2010) 1.46
Imaging the addicted human brain. Sci Pract Perspect (2007) 1.45
Feeding and reward: perspectives from three rat models of binge eating. Physiol Behav (2011) 1.44
Endocannabinoids promote cocaine-induced impulsivity and its rapid dopaminergic correlates. Biol Psychiatry (2013) 1.44
Effects of the plant-derived hallucinogen salvinorin A on basal dopamine levels in the caudate putamen and in a conditioned place aversion assay in mice: agonist actions at kappa opioid receptors. Psychopharmacology (Berl) (2005) 1.43
A Novel, Orally Bioavailable Nociceptin Receptor Antagonist, LY2940094, Reduces Ethanol Self-Administration and Ethanol Seeking in Animal Models. Alcohol Clin Exp Res (2016) 1.42
Differential neurochemical and behavioral adaptation to cocaine after response contingent and noncontingent exposure in the rat. Psychopharmacology (Berl) (2006) 1.42
Molecular profiling of midbrain dopamine regions in cocaine overdose victims. J Neurochem (2003) 1.42
Kappa-opioid ligands in the study and treatment of mood disorders. Pharmacol Ther (2009) 1.42
Opioid-sensitive GABA inputs from rostromedial tegmental nucleus synapse onto midbrain dopamine neurons. J Neurosci (2011) 1.41
Gene expression differences in mice divergently selected for methamphetamine sensitivity. Mamm Genome (2005) 1.41
Stress, alcohol and drug interaction: an update of human research. Addict Biol (2008) 1.40
Excessive cocaine use results from decreased phasic dopamine signaling in the striatum. Nat Neurosci (2014) 1.40
Ligands selective for alpha4beta2 but not alpha3beta4 or alpha7 nicotinic receptors generalise to the nicotine discriminative stimulus in the rat. Psychopharmacology (Berl) (2006) 1.39
Acetylcholine enhancement in the nucleus accumbens prevents addictive behaviors of cocaine and morphine. Proc Natl Acad Sci U S A (2003) 1.39
Nicotinic cholinergic synaptic mechanisms in the ventral tegmental area contribute to nicotine addiction. Learn Mem (2004) 1.38
Abuse and dependence liability of benzodiazepine-type drugs: GABA(A) receptor modulation and beyond. Pharmacol Biochem Behav (2008) 1.36
Convergent processing of both positive and negative motivational signals by the VTA dopamine neuronal populations. PLoS One (2011) 1.36
Self-administration of psychoactive substances by the monkey. Psychopharmacologia (1969) 3.75
Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res (1975) 2.89
Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour. Acta Physiol Scand Suppl (1971) 2.79
U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist. J Pharmacol Exp Ther (1983) 2.65
Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning. Psychopharmacology (Berl) (1985) 2.16
Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine but not heroin self-administration in rats. Psychopharmacology (Berl) (1984) 2.13
Bremazocine: a potent, long-acting opiate kappa-agonist. Life Sci (1980) 1.87
A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activities. J Med Chem (1980) 1.80
Intracranial self-administration of morphine into the ventral tegmental area in rats. Life Sci (1981) 1.77
Electrophysiological evidence for excitation of rat ventral tegmental area dopamine neurons by morphine. Neuroscience (1984) 1.66
In vivo measurement of dopamine and its metabolites by intracerebral dialysis: changes after d-amphetamine. J Neurochem (1983) 1.60
Cocaine-induced place preference conditioning: lack of effects of neuroleptics and 6-hydroxydopamine lesions. Brain Res (1982) 1.47
Ethanol stimulates the firing rate of nigral dopaminergic neurons in unanesthetized rats. Brain Res (1984) 1.43
Attenuation of intravenous amphetamine reinforcement by central dopamine blockade in rats. Psychopharmacology (Berl) (1976) 1.43
Pharmacologic characterization of nicotine-induced conditioned place preference. Pharmacol Biochem Behav (1985) 1.42
An opioid benzodiazepine. Nature (1982) 1.39
Dopaminergic substrates of amphetamine-induced place preference conditioning. Brain Res (1982) 1.35
Action of drugs of abuse on brain reward systems: an update with specific attention to opiates. Pharmacol Biochem Behav (1982) 1.34
Dopamine release and metabolism in awake rats after systemic neuroleptics as studied by trans-striatal dialysis. J Neurosci (1985) 1.31
Electrophysiological actions of nicotine on substantia nigra single units. Br J Pharmacol (1985) 1.31
Toward understanding ethanol's capacity to be reinforcing: a conditioned place preference following injections of ethanol. Pharmacol Biochem Behav (1985) 1.30
Behavioral effects of a novel kappa opioid analgesic, U-50488, in rats and rhesus monkeys. Psychopharmacology (Berl) (1985) 1.26
Attenuation by haloperidol of place preference conditioning using food reinforcement. Psychopharmacology (Berl) (1982) 1.22
Preference conditioning produced by opioid active and inactive isomers of levorphanol and morphine in rat. Life Sci (1986) 1.20
Neuroleptics block the positive reinforcing effects of amphetamine but not of morphine as measured by place conditioning. Pharmacol Biochem Behav (1985) 1.20
Some determinants of the motivational properties of ethanol in the rat: concurrent administration of food or social stimuli. Psychopharmacology (Berl) (1985) 1.12
Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science (1999) 4.31
Preferential stimulation of dopamine release in the nucleus accumbens of freely moving rats by ethanol. J Pharmacol Exp Ther (1986) 2.30
Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J Pharmacol Exp Ther (1988) 2.29
Microdialysis measurement of cortical and hippocampal acetylcholine release during sleep-wake cycle in freely moving cats. Brain Res (1995) 1.90
Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. Eur J Pharmacol (1986) 1.73
Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats. Neuroscience (1989) 1.49
Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse. Behav Brain Res (2001) 1.46
Dopamine release and metabolism in awake rats after systemic neuroleptics as studied by trans-striatal dialysis. J Neurosci (1985) 1.31
Enhancement of memory in cannabinoid CB1 receptor knock-out mice. Eur J Pharmacol (1999) 1.19
Complex pharmacology of natural cannabinoids: evidence for partial agonist activity of delta9-tetrahydrocannabinol and antagonist activity of cannabidiol on rat brain cannabinoid receptors. Life Sci (1998) 1.14
Ethanol preferentially stimulates dopamine release in the nucleus accumbens of freely moving rats. Eur J Pharmacol (1985) 1.05
Preferential stimulation of dopamine release in the nucleus accumbens by opiates, alcohol, and barbiturates: studies with transcerebral dialysis in freely moving rats. Ann N Y Acad Sci (1986) 1.00
Impaired long-term potentiation induction in dentate gyrus of calretinin-deficient mice. Proc Natl Acad Sci U S A (1997) 0.99
In-vivo brain dialysis of neurotransmitters. Trends Pharmacol Sci (1990) 0.97
Enhanced long-term potentiation in mice lacking cannabinoid CB1 receptors. Neuroscience (2000) 0.94
Cannabinoid penetration into mouse brain as determined by ex vivo binding. Eur J Pharmacol (1999) 0.93
Acute stress induces time-dependent responses in dopamine mesolimbic system. Brain Res (1991) 0.91
Glutamate uptake is decreased tardively in the spinal cord of FALS mice. Neuroreport (1998) 0.88
Lack of morphine-induced dopamine release in the nucleus accumbens of cannabinoid CB(1) receptor knockout mice. Eur J Pharmacol (1999) 0.88
Chronic ethanol consumption in rats: correlation between memory performance and hippocampal acetylcholine release in vivo. Neuroscience (1996) 0.88
Biochemical and behavioural properties of clozapine. Psychopharmacology (Berl) (1989) 0.86
Hemisynaptic distribution patterns of presenilins and beta-APP isoforms in the rodent cerebellum and hippocampus. Synapse (2000) 0.85
Riluzole prolongs survival and delays muscle strength deterioration in mice with progressive motor neuronopathy (pmn). J Neurol Sci (2000) 0.85
The central cholinergic system has a role in the antinociception induced in rodents and guinea pigs by the antimigraine drug sumatriptan. J Pharmacol Exp Ther (1996) 0.84
Veillonellae: personal observation of a fatal bacteremia. Boll Ist Sieroter Milan (1989) 0.83
Automated brain dialysis of acetylcholine in freely moving rats: detection of basal acetylcholine. Life Sci (1987) 0.83
The antioxidant ebselen prevents neurotoxicity and clinical symptoms in a primate model of Parkinson's disease. Exp Neurol (2000) 0.82
Immunohistochemical analysis of presenilin-1 expression in the mouse brain. FEBS Lett (1996) 0.81
Ouabain-induced increase in dopamine release from mouse striatal slices is antagonized by riluzole. J Pharm Pharmacol (1998) 0.80
Immunohistochemical analysis of presenilin 2 expression in the mouse brain: distribution pattern and co-localization with presenilin 1 protein. Brain Res (1997) 0.80
Enoxaparin reduces cerebral edemaafter photothrombotic injury in the rat. Haemostasis (1999) 0.79
The effects of clozapine and fluperlapine on the in vivo release and metabolism of dopamine in the striatum and in the prefrontal cortex of freely moving rats. Psychopharmacol Bull (1989) 0.79
Spiro-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one derivatives are mixed AMPA and NMDA glycine-site antagonists active in vivo. Bioorg Med Chem Lett (1999) 0.78
Effects of ebselen, a glutathione peroxidase mimic, in several models of mitochondrial dysfunction. Ann N Y Acad Sci (1999) 0.78
Opposite effects of stress on dopamine release in the limbic system of drug-naive and chronically amphetamine-treated rats. Eur J Pharmacol (1997) 0.78
Modulation of basal and stress-induced release of acetylcholine and dopamine in rat brain by abecarnil and imidazenil, two anxioselective gamma-aminobutyric acidA receptor modulators. J Pharmacol Exp Ther (1995) 0.78
The protective effect of riluzole in the MPTP model of Parkinson's disease in mice is not due to a decrease in MPP(+) accumulation. Neuropharmacology (2000) 0.78
Role of dorsal mesencephalic reticular formation and deep layers of superior colliculus as out-put stations for turning behaviour elicited from the substantia nigra pars reticulata. Brain Res (1981) 0.78
A re-evaluation of the role of superior colliculus in turning behaviour. Brain Res (1982) 0.77
Liposomal amphotericin B as first line and secondary prophylactic treatment for visceral leishmaniasis in a patient infected with HIV. Ann Ital Med Int (2000) 0.77
L-alpha-glycerylphosphorylcholine antagonizes scopolamine-induced amnesia and enhances hippocampal cholinergic transmission in the rat. Eur J Pharmacol (1992) 0.77
The effect of riluzole and mannitol on cerebral oedema after cryogenic injury in the mouse. Neurosci Lett (1999) 0.77
Prognostic significance of Lewis y antigen in resected stage I and II non-small cell lung cancer. Chest (1998) 0.77
Rapid tolerance to neuroleptic-induced stimulation of dopamine release in freely moving rats. J Pharmacol Exp Ther (1985) 0.76
Role of substantia nigra pars reticulata neurons in the expression of neuroleptic-induced catalepsy. Brain Res (1981) 0.76
Brain dialysis of neurotransmitters: a commentary. J Neurosci Methods (1990) 0.76
Role of dorsal mesencephalic reticular formation and deep layers of superior colliculus in turning behaviour elicited from the striatum. Brain Res (1981) 0.75
Behavioural effects of GABA-agonists and antagonists infused in the mesencephalic reticular formation - deep layers of superior colliculus. Brain Res (1981) 0.75
Indeno[1,2-b]pyrazin-2,3-diones: a new class of antagonists at the glycine site of the NMDA receptor with potent in vivo activity. J Med Chem (2000) 0.75
Fastigial influences on postural tonus as studied by kainate lesions and by local infusion of GABAergic drugs in the rat. Brain Res (1984) 0.75
Role of GABA neurons in the expression of striatal motor functions. Adv Biochem Psychopharmacol (1981) 0.75
Effects of RPR 118723, a novel antagonist at the glycine site of the NMDA receptor, in vitro. Eur J Pharmacol (2000) 0.75
A phase II study of oral fluorouracil for gastrointestinal cancer. Anticancer Drugs (1996) 0.75
[Motor and postural effects in intracerebellar injection of kainic acid: possible role of the bulbar reticular formation]. Boll Soc Ital Biol Sper (1983) 0.75
Motor and postural effects of kainic acid or GABA agonist and antagonist injection into the cerebellar nucleus fastigii. Birth Defects Orig Artic Ser (1983) 0.75
Effect of barbiturates and benzodiazepines on local kainate toxicity in the striatum and in the retina. Adv Biochem Psychopharmacol (1981) 0.75
A new pharmacological approach to the facilitation of acetylcholine transmission. Clin Neuropharmacol (1992) 0.75
[Aspecific immunity in infancy and childhood]. Minerva Pediatr (1971) 0.75
Ordered disorder in the aged brain. Adv Exp Med Biol (1991) 0.75
Decreased surface antigen density on lymphocytes of elderly humans. Ann Ital Med Int (2000) 0.75
Benzodiazepines prevent kainate-induced loss of GABAergic and cholinergic neurons in the chick retina. Brain Res (1981) 0.75
[Interaction between viruses and basic substances. I. Effect of methyl-lysozyme on influenza virus: infecting and antigenic activity of the complexes]. Ig Mod (1966) 0.75
8-Methylureido-4,5-dihydro-4-oxo-10H-imidazo[1,2-a]indeno[1,2-e]pyrazines: highly potent in vivo AMPA antagonists. Bioorg Med Chem Lett (2000) 0.75
8-Methylureido-10-amino-10-methyl-imidazo[1,2-a]indeno[1,2-e] pyrazine-4-ones: highly in vivo potent and selective AMPA receptor antagonists. Bioorg Med Chem (2000) 0.75
4,10-Dihydro-4-oxo-4H-imidazo[1,2-a]indeno[1,2-e]pyrazin-2-carboxylic acid derivatives: highly potent and selective AMPA receptors antagonists with in vivo activity. Bioorg Med Chem Lett (2000) 0.75